Evidence map›Paper›PMID 31296199›Full record

ArticleBMC medical informatics and decision making2019

Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making.

Anshu Ankolekar, Ben G L Vanneste, Esther Bloemen-van Gurp, Joep G van Roermund, Evert J van Limbergen, Kees van de Beek, Tom Marcelissen, Victor Zambon, Matthias Oelke, Andre Dekker and 4 more

Abstract readValidation Study
In one paragraph

Article in BMC medical informatics and decision making, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anshu AnkolekarDepartment of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Dr. Tanslaan 12, 6229, ET, Maastricht, The Netherlands.
Ben G L VannesteDepartment of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Dr. Tanslaan 12, 6229, ET, Maastricht, The Netherlands.
Esther Bloemen-van GurpFontys University of Applied Sciences, Eindhoven, The Netherlands.
Joep G van RoermundDepartment of Urology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Evert J van LimbergenDepartment of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Dr. Tanslaan 12, 6229, ET, Maastricht, The Netherlands.
Kees van de BeekDepartment of Urology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Tom MarcelissenDepartment of Urology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Victor ZambonZuyderland Medical Center, Sittard, The Netherlands.
Matthias OelkeDepartment of Urology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Andre DekkerDepartment of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Dr. Tanslaan 12, 6229, ET, Maastricht, The Netherlands.
Cheryl RoumenDepartment of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Dr. Tanslaan 12, 6229, ET, Maastricht, The Netherlands.
Philippe LambinThe D-Lab, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht University, Maastricht, The Netherlands.
Adriana BerlangaDepartment of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Dr. Tanslaan 12, 6229, ET, Maastricht, The Netherlands.
Rianne FijtenDepartment of Radiation Oncology (MAASTRO Clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Dr. Tanslaan 12, 6229, ET, Maastricht, The Netherlands. rianne.fijten@maastro.nl.ORCID 0000-0002-1964-6317

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient decision aids (PDAs) can support the treatment decision making process and empower patients to take a proactive role in their treatment pathway while using a shared decision-making (SDM) approach making participatory medicine possible. The aim of this study was to develop a PDA for prostate cancer that is accurate and user-friendly.

methodsWe followed a user-centered design process consisting of five rounds of semi-structured interviews and usability surveys with topics such as informational/decisional needs of users and requirements for PDAs. Our user-base consisted of 8 urologists, 4 radiation oncologists, 2 oncology nurses, 8 general practitioners, 19 former prostate cancer patients, 4 usability experts and 11 healthy volunteers.

resultsInformational needs for patients centered on three key factors: treatment experience, post-treatment quality of life, and the impact of side effects. Patients and clinicians valued a PDA that presents balanced information on these factors through simple understandable language and visual aids. Usability questionnaires revealed that patients were more satisfied overall with the PDA than clinicians; however, both groups had concerns that the PDA might lengthen consultation times (42 and 41%, respectively). The PDA is accessible on http://beslissamen.nl/ .

conclusionsUser-centered design provided valuable insights into PDA requirements but challenges in integrating diverse perspectives as clinicians focus on clinical outcomes while patients also consider quality of life. Nevertheless, it is crucial to involve a broad base of clinical users in order to better understand the decision-making process and to develop a PDA that is accurate, usable, and acceptable.

Indexed as

Decision Making, SharedDecision Support TechniquesPatient ParticipationAdultHumansMaleNursesOncology NursingPatient Education as TopicPhysiciansProstatic NeoplasmsUrologyPatient decision aidPatient educationProstate cancerShared decision-makingUser-centered design

Identifiers

PMID31296199
PMCPMC6624887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.